These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34503873)

  • 1. Pathological complete response after multi-disciplinary treatment mode in locally advanced rectal cancer.
    Duan Y; Liu W; Yan D; Wang L
    Asian J Surg; 2021 Dec; 44(12):1627-1628. PubMed ID: 34503873
    [No Abstract]   [Full Text] [Related]  

  • 2. When Should We Expect Curative Results of Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients?
    Georgescu MT; Patrascu T; Serbanescu LG; Anghel RM; Gales LN; Georgescu FT; Mitrica RI; Georgescu DE
    Chirurgia (Bucur); 2021; 116(1):16-23. PubMed ID: 33638322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of Clinical Tumor Characteristics Is Associated with Pathological Regression in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Fu Z; Cai Z; Zhao X; Chen H; He Z; Ma J; Zheng M
    J Gastrointest Surg; 2022 Dec; 26(12):2600-2605. PubMed ID: 36171472
    [No Abstract]   [Full Text] [Related]  

  • 4. Should the RAPIDO schedule represent standard of care in locally advanced rectal cancer?
    Glynne-Jones R; Harrison M
    Ann Oncol; 2022 Aug; 33(8):745-746. PubMed ID: 35568280
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of neoadjuvant chemoradiation in MRI staged locally advanced rectal cancer: Retrospective analysis of 123 Chinese patients.
    Lee SF; Chiang CL; Lee FAS; Wong YW; Poon CM; Wong FCS; Tung SY
    J Formos Med Assoc; 2018 Sep; 117(9):825-832. PubMed ID: 29100742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes.
    Kong JC; Soucisse M; Michael M; Tie J; Ngan SY; Leong T; McCormick J; Warrier SK; Heriot AG
    Ann Surg Oncol; 2021 Nov; 28(12):7476-7486. PubMed ID: 33891203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal wait between long-course neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: a dilemma.
    Aggarwal G; Roy MK; Banerjee S
    ANZ J Surg; 2014; 84(1-2):4-5. PubMed ID: 24616925
    [No Abstract]   [Full Text] [Related]  

  • 8. Facility Variation in Local Staging of Rectal Adenocarcinoma and its Contribution to Underutilization of Neoadjuvant Therapy.
    Swords DS; Brooke BS; Skarda DE; Stoddard GJ; Tae Kim H; Sause WT; Scaife CL
    J Gastrointest Surg; 2019 Jun; 23(6):1206-1217. PubMed ID: 30421120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological response post neoadjuvant therapy for locally advanced rectal cancer is an independent predictor of survival.
    On J; Shim J; Mackay C; Murray G; Samuel L; Parnaby C; Ramsay G
    Colorectal Dis; 2021 Jun; 23(6):1326-1333. PubMed ID: 33394572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer.
    Sada YH; Tran Cao HS; Chang GJ; Artinyan A; Musher BL; Smaglo BG; Massarweh NN
    J Surg Res; 2018 Jun; 226():15-23. PubMed ID: 29661280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two Cases of Pathological Complete Response with Neoadjuvant Therapy for Advanced Rectal Cancer].
    Matsuda C; Danno K; Miyazaki S; Fujitani K; Kubota M; Motoori M; Nakatsuka R; Okumura Y; Nomura M; Nishimura M; Kitagawa A; Matsuura N; Fushimi H; Iwase K
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2313-5. PubMed ID: 26805348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Daniel ES; Gibbs P; Guerrieri M; Faragher I
    Colorectal Dis; 2014 Oct; 16(10):783-7. PubMed ID: 24786681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer.
    Ren DL; Li J; Yu HC; Peng SY; Lin WD; Wang XL; Ghoorun RA; Luo YX
    World J Gastroenterol; 2019 Jan; 25(1):118-137. PubMed ID: 30643363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer].
    Fan J; Zhu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):527-533. PubMed ID: 31238633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all!
    Ozer L; Yildiz I; Bayoglu V; Bozkurt M; Esen E; Remzi FH; Gogenur I; Aytac E
    Colorectal Dis; 2021 Jul; 23(7):1662-1669. PubMed ID: 33829626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Chemotherapy Completion on the Efficacy of Irinotecan in the Preoperative Chemoradiotherapy of Locally Advanced Rectal Cancer: An Expanded Analysis of the CinClare Phase III Trial.
    Wang J; Fan J; Li C; Yang L; Wan J; Zhang H; Zhang Z; Zhu J
    Clin Colorectal Cancer; 2020 Jun; 19(2):e58-e69. PubMed ID: 32265117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Pathological Response After Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer and Its Relationship to the Degree of T3 Mesorectal Invasion.
    Wilkins S; Haydon A; Porter I; Oliva K; Staples M; Carne P; McMurrick P; Bell S
    Dis Colon Rectum; 2016 May; 59(5):361-8. PubMed ID: 27050597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.